Levine Zurit 4

What Happened
Levine Zurit, SVP of Business Development at Compugen Ltd (CGEN), exercised 1,875 options at $0.83 per share (cost $1,555) on July 9, 2026 and sold 1,875 common shares in an open-market transaction the same day at $2.50 per share (gross proceeds $4,688). The filing also shows a $0.00 disposition of a derivative instrument for 1,875 shares, which reflects the option conversion/cancellation on exercise. Net proceeds from the simple math of sale minus exercise cost are about $3,133 before fees and taxes.

Key Details

• Transaction date: July 9, 2026. Form 4 filed: July 13, 2026 (timely within required reporting window).
• Exercise: 1,875 shares @ $0.83 — aggregate cost reported $1,555 (code M).
• Sale: 1,875 shares @ $2.50 — gross proceeds $4,688 (code S).
• Derivative disposition: 1,875 @ $0.00, reflecting cancellation/conversion on exercise.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 — sale was made pursuant to a Rule 10b5-1 trading plan adopted Dec 23, 2025. F2 — option vesting: 25% vested Dec 31, 2023; remaining vests in 12 equal quarterly installments, subject to continued service.

Context
Because the exercised shares were sold the same day in equal quantity, this appears to be a same-day exercise and sale (commonly a cashless exercise or sell-to-cover pattern). The transaction was executed under a pre-established 10b5-1 plan, which typically means the trades were pre-authorized and scheduled in advance rather than being ad hoc. This is a routine insider liquidity event and should be read as reporting of transaction activity, not as a direct statement of future company performance.